- Home
- PCRX vs PDM Comparison
PCRX vs PDM Comparison
Compare PCRX & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCRX | PDM |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.0M | 1.0B |
| IPO Year | 2010 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PCRX | PDM |
|---|---|---|
| Price | $25.96 | $9.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $30.25 | $9.00 |
| AVG Volume (30 Days) | 479.1K | ★ 988.5K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | $541,533,000.00 | ★ $564,994,000.00 |
| Revenue This Year | $6.78 | $4.21 |
| Revenue Next Year | $8.54 | $1.29 |
| P/E Ratio | $370.43 | ★ N/A |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $6.32 |
| 52 Week High | $27.64 | $9.99 |
Technical Indicators
Market Signals| Indicator | PCRX | PDM |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 61.92 |
| Support Level | $21.89 | $7.83 |
| Resistance Level | $26.94 | $9.89 |
| Average True Range (ATR) | 0.82 | 0.23 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 56.59 | 77.30 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.